Inguinal Hernia is one of the most common problems affecting the population coming with groin pain. Objective: To find the incidence of occult inguinal hernia diagnosed with ultrasound in patients with groin pain. Methods: Descriptive study was conducted at Gilani Ultrasound Centre. Data of 200 participants were designated done with suitable sample method. Data were analyzed by SSPS version 24.0. Results: Out of 200 male patients the Mean Age ± SD ratio is 23.1±15.7. 38(19%) patients presented with pain bilaterally, left sided pain was presented in 43(21.5%) patients and right sided pain was presented in 119(59.5%) patients. In 25(12.5%) patients occult inguinal hernia was detected and in 175(87.5%) patients occult inguinal hernia was not detected. In 2(1%) patients occult inguinal hernia was detected bilaterally, in 6(3%) patients occult inguinal hernia was detected on left side and in 17(8.5%) patients it was detected on right side. The mean size of the defect on right side was 2.24 and on left side was 5.0. Conclusions: Study concluded that occult inguinal hernia detected in 12.5% patients and majority of them were young adults. Due to the sensitive nature of groin ultrasound, patients may be referred for it if the results of the clinical examination are inconclusive or negative.
The most prevalent abdominal emergency is acute appendicitis. Atypical manifestations may lead to diagnostic uncertainty and a delay in therapy, even if the clinical diagnosis may be simple in patients who exhibit conventional signs and symptoms. When laboratory results are presented, they often show a left shift and an increased leukocytosis. The chance of increased C-reactive protein measurement is high. Imaging modalities have become extremely important in the diagnostic work-up of patients with suspected acute appendicitis in order to maintain the low rate of negative appendectomy because the clinical diagnosis of acute appendicitis continues to pose a challenge to emergency physicians and surgeons. Ultrasound, computed tomography and magnetic resonance imaging modalities are used in diagnosis but we feel that all patients with suspected appendicitis should get an ultrasound. Because ultrasound has outstanding specificity, readily available, no ionizing radiation and cost is low.
Fetal ventriculomegaly (VM) is a dilation of the lateral ventricle. Different patients have different etiologies for fetal ventriculomegaly, which can be idiopathic, structural, or chromosomal. A measurement of 10–15 mm is commonly referred to as mild ventriculomegaly, while measurements of 15–20 and >20 mm and above are defined as moderate and severe ventriculomegaly. Objective: To find the frequency of spinal defects (SD) in fetuses with ventriculomegaly (VM). Methods: It was a cross-sectional analytical study which included 103 pregnant ladies who had evidence of ventriculomegaly visited multiple centers during research period. Convenient sampling method was used. The presence of ventriculomegaly was confirmed using transabdominal probe with frequency 3-5 MHz. Frequency was calculated and crosstabs were made using SPSS version 21.0. Results: Among 103 pregnant patients, frequency of fetal spinal defects was 25.2%. Frequency of ventriculomegaly was as follow: mild ventriculomegaly 43.7%, moderate ventriculomegaly 31.2%, and severe ventriculomegaly 25.2%. Among 103 patients, 25.2% patients had AFI greater than 21. Frequency of mother's H/O any fetal spinal defects in their previous pregnancies was 15.5%. Conclusions: The study concluded that frequency of spinal defects in fetuses with ventriculomegaly was 25.2% and spinal defects occur in those patients who had severe ventriculomegaly (>20mm) and had AFI greater than 25
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.